Medicine
Meropenem 2 g injection
Meropenem 2 g injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
The dry powder should be stored at 20°C to 25ºC (68°F to 77ºF). Brief exposure…
Key facts
- Active ingredient (INN)
- Meropenem
- Brand
- Sold under the generic name
- Strength
- 2 g
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 6 injection
- Manufacturers
- Brooks SteriscienceMylan Institutional
- Origin register
- US FDA, United States
- Storage
- The dry powder should be stored at 20°C to 25ºC (68°F to 77ºF). Brief exposure to 15°C to 30°C (59°F to 86°F) is permitted.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DH02 Meropenem
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 June 2025
- Identifiers
- RxCUI 2664894DailyMed set ID f5154b6f-bca8-4f1e-907b-48ea34caf483, 6902fee1-6022-4145-a79a-4680ad1fb1e8NDC 72078-081, 81962-002Application ANDA219084
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 injection in 1 carton | 81962-002-08 | Brooks Steriscience | 27 June 2025 |
| 6 injection in 1 carton | 72078-081-06 | Mylan Institutional | 1 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 June 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meropenem
Clinical summary
Meropenem is a penem antibacterial indicated for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only), among other approved uses. MedsAcross supplies Meropenem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeropenemFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Meropenem and Sodium Chloride prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Meropenem 2 g injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.